Inhibition of atypical protein kinase C‑ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade

Apostolatos,André   H.; Ratnayake,Wishrawana   S.; Win-Piazza,Hla; Apostolatos,Christopher   A.; Smalley,Tracess; Kang,Loveleen; Salup,Raoul; Hill,Robert; Acevedo-Duncan,Mildred

doi:10.3892/ijo.2018.4542

Inhibition of atypical protein kinase C‑ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade

Authors:
- André H. Apostolatos
- Wishrawana S. Ratnayake
- Hla Win-Piazza
- Christopher A. Apostolatos
- Tracess Smalley
- Loveleen Kang
- Raoul Salup
- Robert Hill
- Mildred Acevedo-Duncan
View Affiliations

Affiliations: Department of Chemistry, University of South Florida, Tampa, FL 33620, USA, Department of Cell Biology, Microbiology and Molecular Biology, University of South Florida, Tampa, FL 33620, USA
Published online on: August 28, 2018 https://doi.org/10.3892/ijo.2018.4542
Pages: 1836-1846
Copyright: © Apostolatos et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Prostate cancer (PC) is the most common type of cancer among men. Aggressive and metastatic PC results in life-threatening tumors, and represents one of the leading causes of mortality in men. Previous studies of atypical protein kinase C isoforms (aPKCs) have highlighted its role in the survival of cultured prostate cells via the nuclear factor (NF)-κB pathway. The present study showed that PKC‑ι was overexpressed in PC samples collected from cancer patients but not in non-invasive prostate tissues, indicating PKC‑ι as a possible prognostic biomarker for the progression of prostate carcinogenesis. Immunohistochemical staining further confirmed the association between PKC‑ι and the prostate malignancy. The DU‑145 and PC‑3 PC cell lines, and the non-neoplastic RWPE‑1 prostatic epithelial cell line were cultured and treated with aPKC inhibitors 2‑acetyl‑1,3-cyclopentanedione (ACPD) and 5-amino‑1-(1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)‑1H-imidazole-4-carboxamide (ICA‑1). Western blot data demonstrated that ICA‑1 was an effective and specific inhibitor of PKC‑ι and that ACPD inhibited PKC‑ι and PKC‑ζ. Furthermore, the two inhibitors significantly decreased malignant cell proliferation and induced apoptosis. The inhibitors showed no significant cytotoxicity towards the RWPE‑1 cells, but exhibited cytostatic effects on the DU‑145 and PC‑3 cells prior to inducing apoptosis. The inhibition of aPKCs significantly reduced the translocation of NF-κB to the nucleus. Furthermore, this inhibition promoted apoptosis, reduced signaling for cell survival, and reduced the proliferation of PC cells, whereas the normal prostate epithelial cells were relatively unaffected. Overall, the results suggested that PKC‑ι and PKC‑ζ are essential for the progression of PC, and that ACPD and ICA‑1 can be effectively used as potential inhibitors in targeted therapy.

View Figures

View References

1	American Cancer Society: Key statistics for prostate cancer. Prostate Cancer Facts. https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html
2	Kume H, Kawai T, Nagata M, Azuma T, Miyazaki H, Suzuki M, Fujimura T, Nakagawa T, Fukuhara H and Homma Y: Intermittent docetaxel chemotherapy is feasible for castration-resistant prostate cancer. Mol Clin Oncol. 3:303–307. 2015. View Article : Google Scholar : PubMed/NCBI
3	Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullén A, et al: Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. Oncotarget. 6:21740–21754. 2015. View Article : Google Scholar : PubMed/NCBI
4	Newton AC: Protein kinase C: Poised to signal. Am J Physiol Endocrinol Metab. 298:E395–E402. 2010. View Article : Google Scholar :
5	Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:607–614. 1992. View Article : Google Scholar : PubMed/NCBI
6	Selbie LA, Schmitz-Peiffer C, Sheng Y and Biden TJ: Molecular cloning and characterization of PKC iota, an atypical isoform of protein kinase C derived from insulin-secreting cells. J Biol Chem. 268:24296–24302. 1993.PubMed/NCBI
7	Hirai T, Niino YS and Chida K: PKC zeta II, a small molecule of protein kinase C zeta, specifically expressed in the mouse brain. Neurosci Lett. 348:151–154. 2003. View Article : Google Scholar : PubMed/NCBI
8	Hayashi A, Seki N, Hattori A, Kozuma S and Saito T: PKCnu, a new member of the protein kinase C family, composes a fourth subfamily with PKCmu. Biochim Biophys Acta. 1450:99–106. 1999. View Article : Google Scholar : PubMed/NCBI
9	Persons DA, Wilkison WO, Bell RM and Finn OJ: Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-I cDNA. Cell. 52:447–458. 1988. View Article : Google Scholar : PubMed/NCBI
10	Housey GM, Johnson MD, Hsiao WL, O’Brian CA, Murphy JP, Kirschmeier P and Weinstein IB: Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell. 52:343–354. 1988. View Article : Google Scholar : PubMed/NCBI
11	Kamata T, Sullivan NF and Wooten MW: Reduced protein kinase C activity in a ras-resistant cell line derived from Ki-MSV transformed cells. Oncogene. 1:37–46. 1987.PubMed/NCBI
12	Weyman CM, Taparowsky EJ, Wolfson M and Ashendel CL: Partial down-regulation of protein kinase C in C3H 10T 1/2 mouse fibroblasts transfected with the human Ha-ras oncogene. Cancer Res. 48:6535–6541. 1988.PubMed/NCBI
13	Mizuguchi J, Nakabayashi H, Yoshida Y, Huang KP, Uchida T, Sasaki T, Ohno S and Suzuki K: Increased degradation of protein kinase C without diminution of mRNA level after treatment of WEHI-231 B lymphoma cells with phorbol esters. Biochem Biophys Res Commun. 155:1311–1317. 1988. View Article : Google Scholar : PubMed/NCBI
14	Hudes GR: Signaling inhibitors in the treatment of prostate cancer. Invest New Drugs. 20:159–172. 2002. View Article : Google Scholar : PubMed/NCBI
15	Wu D, Thakore CU, Wescott GG, McCubrey JA and Terrian DM: Integrin signaling links protein kinase Cepsilon to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells. Oncogene. 23:8659–8672. 2004. View Article : Google Scholar : PubMed/NCBI
16	Rusnak JM and Lazo JS: Downregulation of protein kinase C suppresses induction of apoptosis in human prostatic carcinoma cells. Exp Cell Res. 224:189–199. 1996. View Article : Google Scholar : PubMed/NCBI
17	Jaggi M, Rao PS, Smith DJ, Hemstreet GP and Balaji KC: Protein kinase C mu is down-regulated in androgen-independent prostate cancer. Biochem Biophys Res Commun. 307:254–260. 2003. View Article : Google Scholar : PubMed/NCBI
18	Rao PS, Jaggi M, Smith DJ, Hemstreet GP and Balaji KC: Metallothionein 2A interacts with the kinase domain of PKCmu in prostate cancer. Biochem Biophys Res Commun. 310:1032–1038. 2003. View Article : Google Scholar : PubMed/NCBI
19	Inoue T, Yoshida T, Shimizu Y, Kobayashi T, Yamasaki T, Toda Y, Segawa T, Kamoto T, Nakamura E and Ogawa O: Requirement of androgen-dependent activation of protein kinase Czeta for androgen-dependent cell proliferation in LNCaP Cells and its roles in transition to androgen-independent cells. Mol Endocrinol. 20:3053–3069. 2006. View Article : Google Scholar : PubMed/NCBI
20	Regala RP, Weems C, Jamieson L, Copland JA, Thompson EA and Fields AP: Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity. J Biol Chem. 280:31109–31115. 2005. View Article : Google Scholar : PubMed/NCBI
21	Weichert W, Gekeler V, Denkert C, Dietel M and Hauptmann S: Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis. Int J Oncol. 23:633–639. 2003.PubMed/NCBI
22	Win HY and Acevedo-Duncan M: Atypical protein kinase C phosphorylates IKKalphabeta in transformed non-malignant and malignant prostate cell survival. Cancer Lett. 270:302–311. 2008. View Article : Google Scholar : PubMed/NCBI
23	Regala RP, Weems C, Jamieson L, Khoor A, Edell ES, Lohse CM and Fields AP: Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Res. 65:8905–8911. 2005. View Article : Google Scholar : PubMed/NCBI
24	Desai S, Pillai P, Win-Piazza H and Acevedo-Duncan M: PKC-ι promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway. Biochim Biophys Acta. 1813.1190–1197. 2011.
25	Pillai P, Desai S, Patel R, Sajan M, Farese R, Ostrov D and Acevedo-Duncan M: A novel PKC-ι inhibitor abrogates cell proliferation and induces apoptosis in neuroblastoma. Int J Biochem Cell Biol. 43:784–794. 2011. View Article : Google Scholar : PubMed/NCBI
26	Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. 1976. View Article : Google Scholar : PubMed/NCBI
27	Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680–685. 1970. View Article : Google Scholar : PubMed/NCBI
28	Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. 1979.Biotechnology. 24:145–149. 1992.
29	Allred DC, Harvey JM, Berardo M and Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 11:155–168. 1998.PubMed/NCBI
30	Ratnayake WS, Apostolatos AH, Ostrov DA and Acevedo- Duncan M: Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis. Int J Oncol. 51:1370–1382. 2017. View Article : Google Scholar : PubMed/NCBI
31	Diaz-Meco MT, Municio MM, Sanchez P, Lozano J and Moscat J: Lambda-interacting protein, a novel protein that specifically interacts with the zinc finger domain of the atypical protein kinase C isotype lambda/iota and stimulates its kinase activity in vitro and in vivo. Mol Cell Biol. 16:105–114. 1996. View Article : Google Scholar : PubMed/NCBI
32	Eder AM, Sui X, Rosen DG, Nolden LK, Cheng KW, Lahad JP, Kango-Singh M, Lu KH, Warneke CL, Atkinson EN, et al: Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci USA. 102:12519–12524. 2005. View Article : Google Scholar : PubMed/NCBI
33	Selzer E, Okamoto I, Lucas T, Kodym R, Pehamberger H and Jansen B: Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage. Melanoma Res. 12:201–209. 2002. View Article : Google Scholar : PubMed/NCBI
34	Li Q, Wang J-M, Liu C, Xiao B-L, Lu J-X and Zou S-Q: Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma. Hepatobiliary Pancreat Dis Int. 7:70–75. 2008.PubMed/NCBI
35	Patel R, Win H, Desai S, Patel K, Matthews JA and Acevedo- Duncan M: Involvement of PKC-iota in glioma proliferation. Cell Prolif. 41:122–135. 2008. View Article : Google Scholar : PubMed/NCBI
36	Yang Y-L, Chu J-Y, Luo M-L, Wu YP, Zhang Y, Feng YB, Shi ZZ, Xu X, Han YL, Cai Y, et al: Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma. Genes Chromosomes Cancer. 47:127–136. 2008. View Article : Google Scholar
37	Justilien V, Walsh MP, Ali SA, Thompson EA, Murray NR and Fields AP: The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma. Cancer Cell. 25:139–151. 2014. View Article : Google Scholar : PubMed/NCBI
38	Kim S-W, Schifano M, Oleksyn D, Jordan CT, Ryan D, Insel R, Zhao J and Chen L: Protein kinase C-associated kinase regulates NF-κB activation through inducing IKK activation. Int J Oncol. 45:1707–1714. 2014. View Article : Google Scholar : PubMed/NCBI
39	Xie J, Guo Q, Zhu H, Wooten MW and Mattson MP: Protein kinase C iota protects neural cells against apoptosis induced by amyloid beta-peptide. Brain Res Mol Brain Res. 82:107–113. 2000. View Article : Google Scholar : PubMed/NCBI